Eosinophilic Esophagitis - Are We Making Progress?

2,605 views
April 12, 2023

Disclaimer: On February 12, 2024 the FDA approved budesonide oral suspension (EOHILIA), a corticosteroid indicated for 12 weeks of treatment in adult and pediatric patients 11 years of age and older with EoE.

Comments 0
Login to view comments. Click here to Login